4D Molecular Therapeutics, Inc. (FDMT)

4D Molecular Therapeutics Revenue

In the year 2023, 4D Molecular Therapeutics had annual revenue of $20.72M with 562.29% growth. Revenue in the quarter ending December 31, 2023 was $-19.00K, a -101.52% decrease year-over-year.

• Revenue (ttm): $20.72M
• Revenue Growth: +562.29%
• P/S Ratio: 57.40
• Revenue / Employee: $140,973
• Employees: 147
• Market Cap: 1.19B USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	20.72M	17.59M	562.29%
Dec 31, 2022	3.13M	-14.91M	-82.65%
Dec 31, 2021	18.04M	4.43M	32.52%
Dec 31, 2020	13.61M	6.63M	94.85%
Dec 31, 2019	6.99M	-7.14M	-50.56%
Dec 31, 2018	14.13M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.